Stocks · Health care · Pharmaceutical Preparations

Fulcrum Therapeutics, Inc.

FULC Clue Score33
United States Fiscal year ends December CIK 0001680581 Results filed 27 Apr 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Kevin Tang
17 Jul 2026
10% owner
Buy indirect
50,945
$3.52
$179.33K
Kevin Tang
16 Jul 2026
10% owner
Buy indirect
116,671
$3.56
$415.35K
Kevin Tang
15 Jul 2026
10% owner
Buy indirect
107,377
$3.56
$382.26K
Kevin Tang
14 Jul 2026
10% owner
Buy indirect
75,952
$3.58
$271.91K
Kevin Tang
14 Jul 2026
10% owner
Buy indirect
53,651
$3.56
$191.00K
Kevin Tang
13 Jul 2026
10% owner
Buy indirect
12,966
$3.54
$45.90K
Alex Sapir
4 Mar 2024
See Remarks
Buy
43,360
$11.35
$492.03K
Ra Capital Management, L.p.
20 Jan 2023
10% owner
Buy indirect
1,923,076
$13.00
$25.00M
Ra Capital Management, L.p.
4 Jan 2023
10% owner
Buy indirect
58,369
$7.80
$455.09K
Ra Capital Management, L.p.
4 Jan 2023
10% owner
Buy indirect
122,334
$7.03
$859.71K
Ra Capital Management, L.p.
27 Dec 2022
10% owner
Buy indirect
4,089
$5.99
$24.51K
Ra Capital Management, L.p.
19 Dec 2022
10% owner
Buy indirect
98,787
$5.90
$582.81K
Ra Capital Management, L.p.
16 Dec 2022
10% owner
Buy indirect
1,341,420
$5.42
$7.27M
Ra Capital Management, L.p.
15 Dec 2022
10% owner
Buy indirect
237,029
$5.50
$1.30M
Ra Capital Management, L.p.
14 Dec 2022
10% owner
Buy indirect
824,600
$5.46
$4.50M
James A Geraghty
28 Jun 2021
Director
Buy
10,000
$9.16
$91.60K
Peter G. Thomson
28 Jun 2021
VP Finance & Accounting
Buy indirect
2,300
$9.00
$20.70K
Curtis Gale Oltmans
28 Jun 2021
SVP, General Counsel
Buy
1,088
$9.01
$9.80K
Christopher Morabito
28 Jun 2021
Chief Medical Officer
Buy
1,100
$9.16
$10.08K
Mark J Levin
22 Jul 2019
Director
Buy indirect
81,250
$16.00
$1.30M
Casdin Capital, LLC
22 Jul 2019
10% owner
Buy indirect
5,000
$14.50
$72.50K
Casdin Capital, LLC
22 Jul 2019
10% owner
Buy indirect
10,000
$14.50
$145.00K
Casdin Capital, LLC
22 Jul 2019
10% owner
Buy indirect
125,000
$16.00
$2.00M
6 Dimensions Capital, L.P.
22 Jul 2019
10% owner
Buy
118,750
$16.00
$1.90M
Third Rock Ventures III, L.P.
22 Jul 2019
10% owner
Buy
81,250
$16.00
$1.30M
Third Rock Ventures IV, L.P.
22 Jul 2019
10% owner
Buy
81,250
$16.00
$1.30M
Sanofi
22 Jul 2019
10% owner
Buy indirect
93,750
$16.00
$1.50M

What was left out

Form 4 filings counted 183
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 16
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 28
Sales at will 41
Transactions with no price 0
Shares from compensation/vesting 32,104,196
Sales filed before the plan box existed 29
History held since 18 Jul 2019